Optimising Sleep on TRT

Sleep and testosterone exist in a tightly coupled feedback loop. Poor sleep suppresses testosterone production; low testosterone, in turn, disrupts sleep architecture. For men beginning TRT, understanding this relationship — and actively optimising sleep — can meaningfully accelerate the benefits of treatment.

Testosterone secretion follows a circadian rhythm, with the majority released in pulsatile bursts during deep sleep. Studies using polysomnography have shown that restricting sleep to five hours per night for a week can reduce daytime testosterone levels by 10–15% in healthy young men. For men already dealing with low testosterone, chronic poor sleep compounds the hormonal deficit and limits the ceiling on how well TRT can perform.

One important consideration when starting TRT is the relationship with sleep apnoea. Testosterone can stimulate red blood cell production and, in some individuals, affect upper airway muscle tone in ways that may worsen obstructive sleep apnoea (OSA). We screen all patients for OSA symptoms at intake. Men with confirmed or suspected OSA should be evaluated and, where indicated, treated with CPAP before or concurrent with starting TRT.

Practically, sleep hygiene improvements are a high-leverage, zero-cost complement to TRT. The most impactful changes are consistent sleep and wake times (even on weekends), keeping the bedroom cool (around 18°C), limiting blue light exposure in the two hours before bed, and avoiding alcohol within three hours of sleep. Alcohol in particular suppresses REM sleep and reduces overnight testosterone secretion, directly blunting the benefits of treatment.

Many patients on TRT report spontaneous improvements in sleep quality within the first four to eight weeks — particularly reduced night waking and improved sleep depth. This is likely attributable to the mood-stabilising and anxiety-reducing effects of normalised testosterone, as well as reductions in nocturia that some men experience as their hormonal profile improves. Tracking sleep with a wearable device during the first three months of treatment can provide useful data for your clinical consultations.